Published in Cancer Res on May 01, 1990
AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res (2010) 4.89
Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs (1999) 4.32
IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases. J Immunol (1995) 2.02
A precise and efficient stereological method for determining murine lung metastasis volumes. Am J Pathol (2001) 1.28
Long-term in vivo expression of genes introduced by retrovirus-mediated transfer into mammary epithelial cells. J Virol (1991) 1.15
Tumor imaging with multicolor fluorescent protein expression. Int J Clin Oncol (2011) 1.11
MDA-MB-435 human breast carcinoma metastasis to bone. Clin Exp Metastasis (2003) 1.01
Molecular imaging of metastatic potential. J Nucl Med (2008) 0.94
β-Galactosidase-instructed formation of molecular nanofibers and a hydrogel. Nanoscale (2011) 0.85
In vivo models for early development of colorectal liver metastasis. Int J Exp Pathol (2007) 0.83
High-resolution analyses of two different classes of tumor cells in situ tagged with alternative histochemical marker genes. Am J Pathol (1992) 0.82
Characterization of spontaneous metastasis in an aggressive breast carcinoma model using flow cytometry. Clin Exp Metastasis (1999) 0.81
Over-expression of human CD44s in murine 3T3 cells: selection against during primary tumorigenesis and selection for during micrometastasis. Clin Exp Metastasis (1998) 0.77
Complementation of two related tumour cell classes during experimental metastasis tagged with different histochemical marker genes. Br J Cancer (1993) 0.77
The use of genetic marking to assess the interaction of sensitive and multidrug-resistant cells in mixed culture. Br J Cancer (1994) 0.75
Tumour progression of human neuroblastoma cells tagged with a lacZ marker gene: earliest events at ectopic injection sites. Br J Cancer (1994) 0.75
Investigation of Metastasis-Related Genes: A Rat Model Mimicking Liver Metastasis of Colorectal Carcinoma. Front Oncol (2017) 0.75
A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell Dev Biol Anim (1999) 4.93
Contact-inhibited revertant cell lines isolated from SV 40-transformed cells. IV. Microfilament distribution and cell shape in untransformed, transformed, and revertant Balb-c 3T3 cells. J Cell Biol (1973) 2.40
Cell surface heparan sulfate mediates some adhesive responses to glycosaminoglycan-binding matrices, including fibronectin. J Cell Biol (1983) 2.35
CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res (1996) 2.18
Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res (1991) 2.06
Contact-inhibited revertant cell lines isolated from SV40-transformed cells. II. Ultrastructural study. J Cell Biol (1971) 1.96
Fibronectin and proteoglycans as determinants of cell-substratum adhesion. J Supramol Struct (1979) 1.93
Tracking micrometastasis to multiple organs with lacZ-tagged CWR22R prostate carcinoma cells. J Histochem Cytochem (2000) 1.93
Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. Cancer Res (1998) 1.92
Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells. Mol Endocrinol (1997) 1.90
Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. J Natl Cancer Inst (1999) 1.81
Evidence of independent origin of multiple tumors from patients with prostate cancer. J Natl Cancer Inst (1998) 1.81
Contact-inhibited revertant cell lines isolated from simian virus 40-transformed cells. 3. Concanavalin A-selected revertant cells. J Virol (1972) 1.79
CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma. Cancer Res (1994) 1.77
Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3'-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells. Proc Natl Acad Sci U S A (1998) 1.70
Altered expression of RET proto-oncogene product in prostatic intraepithelial neoplasia and prostate cancer. J Natl Cancer Inst (1998) 1.68
Separation of mammalian cells using programmed gradient sedimentation. Exp Mol Pathol (1969) 1.66
Eosinophil infiltration of human colonic carcinomas as a prognostic indicator. Cancer Res (1983) 1.66
Transplantation of human prostatic carcinoma into nude mice in Matrigel. Cancer Res (1991) 1.61
Substrate-attached glycoproteins mediating adhesion of normal and virus-transformed mouse fibroblasts. J Cell Biol (1974) 1.59
Substratum contacts and cytoskeletal reorganization of BALB/c 3T3 cells on a cell-binding fragment and heparin-binding fragments of plasma fibronectin. Exp Cell Res (1986) 1.57
Transfer ribonucleic acid methylases of HeLa cells. Arch Biochem Biophys (1968) 1.51
Providing human tissues for research: how to establish a program. Arch Pathol Lab Med (1998) 1.50
Electrophoretic analysis of substrate-attached proteins from normal and virus-transformed cells. Biochemistry (1976) 1.46
The Cooperative Human Tissue Network. An update. Cancer (1993) 1.45
Glycosaminoglycans in the substrate adhesion sites of normal and virus-transformed murine cells. Biochemistry (1979) 1.44
Use of dextran-conjugated SRBC for the detection of MOPC 104E tumor cells. J Immunol (1972) 1.43
Morphology and cellular origins of substrate-attached material from mouse fibroblasts. Exp Cell Res (1977) 1.43
Two functionally distinct pools of glycosaminoglycan in the substrate adhesion site of murine cells. J Cell Biol (1978) 1.43
Estimation of experimental conditions that permit cell separations by velocity sedimentation on isokinetic gradients of Ficoll in tissue culture medium. Anal Biochem (1971) 1.41
Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions. Cancer Res (2000) 1.38
Contact-inhibited revertant cell lines isolated from SV40-transformed cells. I. Biologic, virologic, and chemical properties. J Cell Biol (1971) 1.37
Glycosaminoglycans that bind cold-insoluble globulin in cell-substratum adhesion sites of murine fibroblasts. Proc Natl Acad Sci U S A (1980) 1.36
Close and focal contact adhesions of fibroblasts to a fibronectin-containing matrix. Fed Proc (1985) 1.36
Evidence that fibronectin is the collagen receptor on platelet membranes. Proc Natl Acad Sci U S A (1978) 1.35
Release of macromolecules from BALB-c mouse cell lines treated with chelating agents. Biochemistry (1972) 1.34
The identification of monoclonality in human aberrant crypt foci. Cancer Res (1999) 1.34
A new method for separating lymphocytes and granulocytes from human peripheral blood using programmed gradient sedimentation in an isokinetic gradient. Immunology (1973) 1.33
Expression of E-cadherin in primary and metastatic prostate cancer. Am J Pathol (1996) 1.31
Problems connected with the separation of different kinds of cells. Int Rev Exp Pathol (1975) 1.29
ErbB kinases and NDF signaling in human prostate cancer cells. Oncogene (1997) 1.28
Rate zonal centrifugation in a Ficoll gradient. Anal Biochem (1969) 1.28
Human colostral cells. I. Separation and characterization. Clin Exp Immunol (1979) 1.27
Separation of mast cells in successive stages of differentiation using programmed gradient sedimentation. Am J Pathol (1970) 1.26
Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis (1992) 1.25
Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon. Carcinogenesis (1995) 1.23
Differences in hyaluronate binding to plasma and cell surface fibronectins. Requirement for aggregation. J Biol Chem (1982) 1.23
Substrate-attached glycoproteins from normal and virus-transformed cells. Biochemistry (1974) 1.23
Selectable plasmid vectors with alternative and ultrasensitive histochemical marker genes. Biotechniques (1991) 1.21
Multiple classes of heparan sulfate proteoglycans from fibroblast substratum adhesion sites. Affinity fractionation on columns of platelet factor 4, plasma fibronectin, and octyl-sepharose. J Biol Chem (1984) 1.18
Beta-catenin expression is altered in human colonic aberrant crypt foci. Cancer Res (2001) 1.17
Methylated bases in DNA of animal origin. Arch Biochem Biophys (1970) 1.16
Fibronectin-mediated adhesion of fibroblasts: inhibition by dermatan sulfate proteoglycan and evidence for a cryptic glycosaminoglycan-binding domain. J Cell Biol (1987) 1.16
Preliminary characterization of the proteoglycans in the substrate adhesion sites of normal and virus-transformed murine cells. Biochemistry (1979) 1.10
Contact formation by fibroblasts adhering to heparan sulfate-binding substrata (fibronectin or platelet factor 4). Exp Cell Res (1983) 1.08
Centrifugation of mammalian cells on gradients: a new rotor. Science (1968) 1.08
Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colon. Gut (2002) 1.08
Aberrant crypts in human colonic mucosa: putative preneoplastic lesions. J Cell Biochem Suppl (1992) 1.04
Stimulation of 2-deoxyglucose uptake in growth-inhibited BALB-C 3T3 and revertant SV40-transformed 3T3 cells. Exp Cell Res (1974) 1.03
Molecular composition and origin of substrate-attached material from normal and virus-transformed cells. J Supramol Struct (1976) 1.03
Cell-type-specific expression of alternatively spliced human fibronectin IIICS mRNAs. Mol Cell Biol (1990) 1.03
Over-expression of transfected N-myc oncogene in human SKNSH neuroblastoma cells down-regulates expression of beta 1 integrin subunit. Oncogene (1995) 1.03
Amplification and rearrangement of the Kirsten ras oncogene in virus-transformed BALB/c 3T3 cells during malignant tumor progression. Proc Natl Acad Sci U S A (1987) 1.02
Complementary adhesive responses of human skin fibroblasts to the cell-binding domain of fibronectin and the heparan sulfate-binding protein, platelet factor-4. Exp Cell Res (1984) 1.00
A new method for separating peritoneal lymphocytes from macrophages. Immunology (1972) 0.98
Partial purification of human colonic carcinoma cells by sedimentation. Br J Cancer (1977) 0.98
Biological roles of dermatan sulphate proteoglycans. Ciba Found Symp (1986) 0.97
Identification of dysplasia in human colonic aberrant crypt foci. Am J Pathol (1997) 0.97
Separation of lymphocytes and macrophages from suspensions of guinea pig peritonitis exudate cells using programmed gradient sedimentation. Am J Pathol (1971) 0.97
The interaction of N-acetylhexosaminidase with insolubilized concanavalin A. Biochem J (1977) 0.96
Heparan sulphate proteoglycan as mediator of some adhesive responses and cytoskeletal reorganization of cells on fibronectin matrices: independent versus cooperative functions. Ciba Found Symp (1986) 0.96
Androgen receptor up-regulates insulin-like growth factor binding protein-5 (IGFBP-5) expression in a human prostate cancer xenograft. Endocrinology (1999) 0.96
Isolation of leukemic blasts from peripheral blood by density gradient centrifugation. J Lab Clin Med (1970) 0.95
Modulation of matrix adhesive responses of human neuroblastoma cells by neighboring sequences in the fibronectins. J Cell Biol (1988) 0.95
Adhesion activity in fibronectin's alternatively spliced domain EDa (EIIIA): complementarity to plasma fibronectin functions. Exp Cell Res (1995) 0.94
Induction of monocyte expression of tumor necrosis factor alpha by the 30-kD alpha antigen of Mycobacterium tuberculosis and synergism with fibronectin. J Clin Invest (1996) 0.94
A characterization of human tonsillar lymphocytes after separation from other tonsillar cells in an isokinetic gradient of ficoll in tissue culture medium. Am J Pathol (1976) 0.94
Separation of malignant cells from transplantable rodent tumors. Exp Mol Pathol (1970) 0.93
Extracellular matrix adhesion-promoting activities of a dermatan sulfate proteoglycan-associated protein (22K) from bovine fetal skin. J Cell Sci (1991) 0.93
Centrifugal elutriation (counterstreaming centrifugation) of cells. Cell Biophys (1979) 0.92
Separation of beating cardiac myocytes from suspensions of heart cells. Am J Pathol (1972) 0.92
Separation of tumor cells by density gradient centrifugation: recent work with human tumors and a discussion of the kind of quantitation needed in cell separation experiments. Biophys Chem (1976) 0.92
Adhesion sites of neural tumor cells: biochemical composition. Biochemistry (1980) 0.91
Evidence for genomic instability in human colonic aberrant crypt foci. Oncogene (1996) 0.91
Substrate-attached serum and cell proteins in adhesion of mouse fibroblasts. J Cell Physiol (1976) 0.91
Enzyme activities in prostatic carcinoma related to Gleason grades. Cancer Res (1985) 0.91
Inducible nitric oxide synthase (iNOS) is expressed similarly in multiple aberrant crypt foci and colorectal tumors from the same patients. Cancer Res (2001) 0.91